None of that means the medication is failing
Weeks 8-12: Peak Effect Window Weeks 8 through 12 represent the peak efficacy window based on the Phase 2 trial duration
For people with insurance coverage, there are usually multiple hoops to jump through, and each insurance companys prior authorization requirements are different, says Allison Rhodes, MD, an internal medicine and obesity medicine physician at the Ohio State University Wexner Medical Center in Columbus
These findings underscore a global trend of underdiagnosed and undertreated DPN, necessitating a paradigm shift in healthcare strategies, robust awareness campaigns, and the implementation of comprehensive screening protocols to address this overlooked burden in patient care
AOD 9604 was specifically engineered to avoid these effects
Drug Product Database Retatrutide is not listed as an authorized health product as of May 2026